期刊文献+

转化医学的实践现状及思考 被引量:8

Thoughts on status quo of translational medicine practice
下载PDF
导出
摘要 比较分析了转化医学与传统医学科研独特的优势,介绍了国内外转化医学研究的实践,指出当前国内推进转化医学研究中存在的认识不一,对转化医学实践模式的认识还比较模糊;机制不全,医学研究实践导向力不足;医研不均,临床和基础发展不平衡;平台不高,医学研究优势资源无法有效整合;人才单一,缺少开展转化医学研究的复合型人才等方面的问题,进而提出要有效整合国内优势的临床和基础研究资源、加速复合型转化医学人才的培养、建立应用为导向的医学科研成果评价机制、注重学习国际先进转化医学实践模式等科学有效开展转化医学研究工作的建议。 Compared with traditional pattern, translational medicine shows its specific advantages in medical research practices, and there grown up lots of instructive explore in many countries. In China, problems which can be described as there are not a consensus opinion on translational medicine research, ambiguous of its practice mode, imperfect mechanism and short of motivation on medicine research practice, imbalance on research and clinical service, lack of efficiency platform to integrate excellent medical research resources and lack of versatile human resources to develop translational medicine research. So it is necessary to integrate excellent clinical service and basic medicine research resources effectively, promote versatile human resources training, build application oriented medical research assessment mechanism and highlight on learning excellent international experience of translational medicine practice mode to effective develop translational medicine research.
出处 《中国医院》 2013年第7期4-6,共3页 Chinese Hospitals
关键词 转化医学 实践 translational medicine, practice
  • 相关文献

参考文献3

二级参考文献11

  • 1LEHMANN C U,ALTUWAIJRI M M,LI Y C, et al. Translational research in medical informatics or from theory to practice[J].Methods Inf Med,2008,47(1) :1-3.
  • 2LITTMAN B H,MARIO L D,PLEBANI M,et al. What's next in translational medicine? [J]. Clin Sci (Lond),2007,112(4) :217 227.
  • 3MARINCOLA F M. Translational Medicine:A two-way road [J].Transl Med,2003,1(1) :1-2.
  • 4JEMAL A,SIEGEI. R,WARD E,et al. Cancer statistics,2007 [J]. CA Cancer J Clin,2007,57 (1):43-66.
  • 5KRIS M G. Foreword: challenging the 'one size-fits-all ' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer [J].Lung Caneer,2008,60(Suppl 2) :S1- 2.
  • 6AMERLING R ,WINCHESTER J F ,RONCO C. Guidelines have done more harm than good [J]. Blood Purif,2008,26(1) :73-76.
  • 7MANDELL B F. Surrogate markers are not 'one size-fits all' [J]. Cleve Clin J Med,2006, 73(5) :416.
  • 8ISSA A M. Personalized medicine and the practice of medicine in the 21st century [J]. Mcgill J Med,2007,10(1):53-57.
  • 9MEYER C R. Personalized medicine[J]. Minn Med,2008,91(5) :4.
  • 10MATHEW J P,TAYLOR B S,BADER G D,et al. From bytes to bedside:data integration and computational biology for translational cancer research [J]. PLoS Comput Biol,2007,3(2) 153-162.

共引文献73

同被引文献101

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部